期刊文献+

重组人白介素-12生物学活性检测方法的建立 被引量:5

下载PDF
导出
摘要 目的建立重组人白介素-12(rhIL-12)的生物学活性检测方法。方法采用重组人白介素-12刺激外周血淋巴细胞分泌IFN-γ,并用国际标准品校正,进行生物学活性检测。结果用该方法对重组人白介素-12成品及原液进行检测,成品比活性平均值为1037460IU/mg,变异系数为26·0%(n=5);原液比活性平均值为1262270IU/mg,变异系数为16·8%(n=5)。结论该方法检测结果准确、客观,重复性好,可用于重组人白介素-12生物学活性的常规检测。
出处 《中国生物制品学杂志》 CAS CSCD 2006年第5期514-515,共2页 Chinese Journal of Biologicals
基金 国家863高技术研究发展计划项目(2003AA2Z3480)
  • 相关文献

参考文献7

二级参考文献23

  • 1高军,朱伟,崔龙,龙建秋,谷爱梅,李茂.含有CD基因的腺病毒载体的构建[J].海军医学杂志,1999,17(2):132-135. 被引量:2
  • 2陈丙莺,马建吟,黄钦田,尤丽芬.简易自然杀伤试验——LDH释放改良法[J].上海免疫学杂志,1989,9(4):218-219. 被引量:104
  • 3LAMONT AG, ADONINI L. IL-12, a Key cytokine in immune regulation[ J]. Immunol Today, 1996, 17(5):214.
  • 4Liesveld JL,Harbol AW,Abboud CN.Stem cell factor and stromal cell co-culture prevent apoptosis in a subculture of the megakaryoblastic cell line,UT-7 [J].Leuk Res,1996,20 (7):591.
  • 5Liesveld JL,Harbol AW,Abboud CN.Stem cell factor and stromal cell co-culture prevent apoptosis in a subculture of the megakaryoblastic cell line,UT-7 [J].Leuk Res,1996,20 ( 7 ):591
  • 6Williams GT.Programmed cell death: Apoptosis and oncogenesis[J].Cell,1991,65(7): 1097
  • 7Wu CY et al. Eur J Immunol,1996;26:345-350
  • 8Car BD et al. Toxicol Pathol,1999;27(1):58-63
  • 9Motzer RJ et al. Clin Cancer Res ,1998 ; 4 :1183-1191
  • 10Rook AH et al. Blood,1999;94(3):902-908

共引文献12

同被引文献46

  • 1王常勇,毛天球,王会信,赵明,白艳婷.人重组骨形成蛋白—2生物学活性及其载体的实验研究[J].实用口腔医学杂志,1997,13(1):3-5. 被引量:2
  • 2Murphy KM, Ouyang W, Farrar JD, et al. Signaling and transcription in T helper development [ J ]. Annu Rev Immunol, 2000, 18(3) :451-494.
  • 3Mavropoulos A, Sully G, Cope AP, et al. Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells [ J]. Blood, 2005, 105( 1 ) :282-288.
  • 4Wolf SF, Temple PA, Kobayashi M, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells [ J]. J Immunol, 1991, 146(9) :3074-3081.
  • 5Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity [ J ]. Nat Rev Immunol, 2003, 3 (2) : 133-146.
  • 6Orleans-Lindsay JK, Deru A, Craig JI, et al. In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic ceils; a strategy for ex-vivo generation of CTL for immunotherapy [ J]. Clin Exp Immunol, 2003, 133(13) :467-475.
  • 7Valenzuela J, Schmidt C, Mescher M. The rules of IL- 12 in providing a third signal for clone expansion of naive CD8^ + T cells [ J]. J Immunol, 2002, 169 (12) :6842-6849.
  • 8Weiss JM,Subleski JJ ,Wigginton JM ,et al. Immunotherapy of cancer by IL-12-based cytokine combinations[ J]. Expert Opin Biol Ther, 2007, 7( 11 ) :1705-1721.
  • 9Del Vecchio M, Bajetta E, Canova S,et al. Interleukin- 12: biological properties and clinical application [ J ]. Clin Cancer Res, 2007, 13 (16) :46774685.
  • 10Kim M. Cytokine therapy in cancer [J]. Expert Opin on Biol Ther, 2008, 8(10) :1495-1505.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部